Cross-border investment and financing projects event in Shenzhen

Cross-border investment and financing projects event in Shenzhen

ARC Capital in Shenzhen!

Tuesday, May 23rd 2017, ARC Capital will host a cross-border investment and financing projects event.

What should be a better investment strategy in terms of globalization? And what should be a proper react due to the recent capital control regulations to diminish your investment risk? We all must have heard about Cross- Border Investment and how is it essential in the emerging markets.

We will identify the demand for companies which would like to take advantage of overseas capital markets, introduce some practical approaches in financing for small-middle sized companies.

Venue: 8F Zhaoshangju Square Building, 1166 Wanghai Road, Nanshan District, Shenzhen, China

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission